Solid Tumors
A Phase 1/Randomized Phase 2 Study to Evaluate LY2603618 in Combination with Gemcitabine in Patients with Pancreatic Cancer
Trial ID: 08095
Contact: Crystal Grant
Phone: (281)863-4630
Learn More about this trial.
go back | new search